Darwin Platform Pharmaceuticals Limited - Company Profile

It is a healthcare public limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Darwin Platform Pharmaceuticals Limited

Darwin Platform Pharmaceuticals Limited, a active public limited company, was established on 03 September 2012 in Mumbai, Maharashtra, India. Engaging in medical consumables & supplies within the trade sector, it holds CIN: U85191MH2012PLC235261. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Manoj Pincha (Additional Director), Vasu Kumar (Director), Rahul Jeewanlal Dhote (Director). Past directors included Devang Navinchandra Shah, Vasu Kumar, Mohammadsalim Harun Lakhani. It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H-Wing, Unit No. 127, Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (Eas, T), Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85191MH2012PLC235261

  • Registration Number

    235261

  • Incorporation Date

    03 September 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.00 Cr
  • Revenue Growth **** 85.33%
  • Profit Growth **** -54.66%
  • Ebitda **** -38.72%
  • Net Worth 0.01%
  • Total Assets **** 0.03%
Company report

Darwin Platform Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Darwin Platform Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Darwin Platform Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Manoj Pincha Additional Director 10 Oct 2023 Current
Vasu Kumar Director 11 Jun 2021 Current
Rahul Jeewanlal Dhote Director 05 Mar 2020 Current
Herambha Mukund Naik Director 29 Sep 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Sep 2012 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Additional Director 06 Nov 2018 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Additional Director 05 Mar 2020 Past
Pramod Abcsdd Director 24 Sep 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Darwin Platform Pharmaceuticals.

Darwin Platform Pharmaceuticals Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 85.33% increase. The company also saw a substantial fall in profitability, with a 54.66% decrease in profit. The company's net worth moved up by a moderate rise of 0.01%.

Darwin Platform Pharmaceuticals revenue growth over time
Darwin Platform Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 85.33%
*******
*******
*******
*******
Revenue from Operations
*******
 85.33%
*******
*******
*******
*******
Total Assets
*******
 0.03%
*******
*******
*******
*******
Profit or Loss
*******
 -54.66%
*******
*******
*******
*******
Net Worth
*******
 0.01%
*******
*******
*******
*******
EBITDA
*******
 -38.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Darwin Platform Pharmaceuticals?

In 2020, Darwin Platform Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹50,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 5.00 Cr
Latest Charge Details
Date Lender Amount Status
23 Jun 2023 State Bank Of India ₹5.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Darwin Platform Pharmaceuticals?

Darwin Platform Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Darwin Platform Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darwin Platform Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Darwin Platform Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Darwin Platform Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Darwin Platform Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I. was recorded as a recent event.

  • Director Appointment

    Progress on Manoj Pincha was appointed as a Additional Director was appointed as a Additional Director on 10 Oct 2023 & has been associated with this company since 2 years 5 months . was documented.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 50.00 M with Charge ID 100753428 was registered on 23 Jun 2023. was documented.

  • Director Appointment

    Vasu Kumar was appointed as a Director was appointed as a Director on 11 Jun 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Rahul Jeewanlal Dhote was appointed as a Director was appointed as a Director on 05 Mar 2020 & has been associated with this company since 6 years 16 days . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Darwin Platform Pharmaceuticals Limited?

The CIN of Darwin Platform Pharmaceuticals Limited is U85191MH2012PLC235261.

Where is Darwin Platform Pharmaceuticals Limited headquartered?

Darwin Platform Pharmaceuticals Limited is headquartered at H-Wing, Unit No. 127, Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (Eas, T), Mumbai, Maharashtra, 400072.

When was Darwin Platform Pharmaceuticals Limited incorporated?

Darwin Platform Pharmaceuticals Limited was incorporated on 03 September 2012.

Who are the current directors of Darwin Platform Pharmaceuticals Limited?

The current directors of Darwin Platform Pharmaceuticals Limited are

What is the primary industry of Darwin Platform Pharmaceuticals Limited?

The primary industry of Darwin Platform Pharmaceuticals Limited is Trade.

Is Darwin Platform Pharmaceuticals Limited a listed company?

Darwin Platform Pharmaceuticals Limited is unlisted.

What is the capital structure of Darwin Platform Pharmaceuticals Limited?

The authorized capital of Darwin Platform Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Darwin Platform Pharmaceuticals Limited?

The compliance status of Darwin Platform Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available